LTIMindtree Launches ‘BlueVerse' — An AI Ecosystem that will Define the Enterprise of the Future
BlueVerse Marketplace currently has over 300 industry and function-specific agents and ensures seamless interoperability and a growing connector ecosystem. It is underpinned by responsible AI governance, delivering enterprise-grade trust and scalability.
BlueVerse Productized Services utilize repeatable frameworks, accelerators, and industry-specific solution kits. At launch, BlueVerse will offer pre-built solutions for Marketing Services and Contact Center as a Service (CCaaS). With Marketing Services businesses can unlock unparalleled campaign effectiveness and achieve maximum ROI, transforming their marketing strategies into powerful growth engines. CCaaS uses context-aware AI agents to reduce response times leading to enhanced customer satisfaction.
This ecosystem also includes BlueVerse Foundry, an intuitive no-code designer and flexible pro-code editor that can enable enterprises to quickly compose and deploy AI agents, AI Tools, assistants, Retrieval-Augmented Generation (RAG) pipelines and intelligent business processes.
Venu Lambu, Chief Executive Officer and Managing Director, LTIMindtree, said, 'BlueVerse is all about unlocking productivity for businesses at different levels by embedding AI across all functions of the enterprise. Backed by a strategic partnership ecosystem and deep AI expertise, it positions LTIMindtree as the partner of choice for future-ready organizations.'
'BlueVerse will enable our clients to unlock new sources of value, streamline operations, and stay ahead in an AI-driven world,' said Nachiket Deshpande, President, Global AI Services, Strategic Deals and Partnerships. 'By embedding advanced AI across core business functions, we aim to deliver measurable outcomes and create long-term competitive advantage for our clients.'
BlueVerse is where autonomous agents and enterprise ambition converge. At LTIMindtree, we're not just bringing AI to business—we're making business Agentic. To learn more about BlueVerse please click here.
About LTIMindtree:
LTIMindtree is a global technology consulting and digital solutions company that enables enterprises across industries to reimagine business models, accelerate innovation, and maximize growth by harnessing digital technologies. As a digital transformation partner to more than 700 clients, LTIMindtree brings extensive domain and technology expertise to help drive superior competitive differentiation, customer experiences, and business outcomes in a converging world. Powered by 84,000+ talented and entrepreneurial professionals across more than 40 countries, LTIMindtree — a Larsen & Toubro Group company — solves the most complex business challenges and delivers transformation at scale. For more information, please visit www.ltimindtree.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
TransLogic™ Showcases Modernization Solutions at Healthcare Facilities Conference
Advanced transport automation enhances patient care and reduces operational costs BROOMFIELD, Colo., July 29, 2025--(BUSINESS WIRE)--TransLogic™, a Swisslog Healthcare company and a leading supplier in transport automation, will demonstrate how modernizing operational technology optimizes healthcare facility operations at the 2025 Health Care Facilities Innovation Conference. The event, July 27-30 in Columbus, Ohio, brings together over 3,000 healthcare facility professionals focused on advancing safety and innovation in the healthcare-built environment. TransLogic will exhibit at booth #906 in the Exhibition Hall, showcasing solutions that streamline internal logistics and boost operational performance through innovations in transport automation. The conference features over 70 speakers and thought leaders, along with 300 exhibitors presenting the latest technologies in healthcare facility management. Attendees can explore TransLogic's Design Assist offering and discuss modernizations that address IT security for pneumatic tube systems. The Design Assist approach brings transport automation experts into the early design phases of hospital construction projects, fostering collaboration that enhances efficiency and ensures long-term serviceability. Modernizations directly address security concerns by upgrading current versions of software & firmware, and installing the most updated hardware that provide robust IT security provisions. "As healthcare facilities face mounting pressure to maximize resources, our trusted operational technology addresses these challenges head-on," said Adam Tappen, Senior Vice President of Sales and Service at TransLogic North America. "Our pneumatic tube systems, proudly made in the USA, offer tangible benefits that facility managers can implement to transform their operations and enhance overall healthcare delivery through thorough early planning, consistent maintenance, and system updates." TransLogic will highlight the significant impact of its systems on healthcare operations. Company research shows that in a 300-bed hospital, a well-designed pneumatic tube system can save approximately $1.3 million annually in courier labor costs, with nurses spending 22% less time searching for missing medications. "The second half of 2025 promises exciting developments for healthcare facilities as we continue to advance visibility into hospital pneumatic tube systems," said Scott Fincher, Product Director, Transport Automation at TransLogic and Swisslog Healthcare. "We'll soon be able to introduce a solution that not only meets today's challenges but anticipates tomorrow's needs, especially in the day-to-day happenings with our facilities partners." For more information about TransLogic and its offerings, visit About Swisslog Healthcare Swisslog Healthcare provides pharmacy workflow automations through robotic solutions and operational technology that enable hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patients' needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways. For more information, visit About TransLogic™ TransLogic™, a Swisslog Healthcare Company, builds on its 100 years of operational technology expertise to reliably automate the delivery of critical items and leverage innovations which transcend industry standards in transport automation. TransLogic™ products are manufactured in the USA, resulting in nominal supply chain issues, fewer shipping delays, and quality controls which meet North America's standards. Learn more about TransLogic™ solutions at View source version on Contacts Media Contacts Erica Fetherston10 to 1 Public Relationserica@ (480) 676-9141 Emily Cardone10 to 1 Public Relationsemily@ (480) 245-3983 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
TransLogic™ Showcases Modernization Solutions at Healthcare Facilities Conference
BROOMFIELD, Colo.--(BUSINESS WIRE)-- TransLogic™, a Swisslog Healthcare company and a leading supplier in transport automation, will demonstrate how modernizing operational technology optimizes healthcare facility operations at the 2025 Health Care Facilities Innovation Conference. The event, July 27-30 in Columbus, Ohio, brings together over 3,000 healthcare facility professionals focused on advancing safety and innovation in the healthcare-built environment. TransLogic will exhibit at booth #906 in the Exhibition Hall, showcasing solutions that streamline internal logistics and boost operational performance through innovations in transport automation. The conference features over 70 speakers and thought leaders, along with 300 exhibitors presenting the latest technologies in healthcare facility management. Attendees can explore TransLogic's Design Assist offering and discuss modernizations that address IT security for pneumatic tube systems. The Design Assist approach brings transport automation experts into the early design phases of hospital construction projects, fostering collaboration that enhances efficiency and ensures long-term serviceability. Modernizations directly address security concerns by upgrading current versions of software & firmware, and installing the most updated hardware that provide robust IT security provisions. "As healthcare facilities face mounting pressure to maximize resources, our trusted operational technology addresses these challenges head-on," said Adam Tappen, Senior Vice President of Sales and Service at TransLogic North America. "Our pneumatic tube systems, proudly made in the USA, offer tangible benefits that facility managers can implement to transform their operations and enhance overall healthcare delivery through thorough early planning, consistent maintenance, and system updates." TransLogic will highlight the significant impact of its systems on healthcare operations. Company research shows that in a 300-bed hospital, a well-designed pneumatic tube system can save approximately $1.3 million annually in courier labor costs, with nurses spending 22% less time searching for missing medications. "The second half of 2025 promises exciting developments for healthcare facilities as we continue to advance visibility into hospital pneumatic tube systems," said Scott Fincher, Product Director, Transport Automation at TransLogic and Swisslog Healthcare. "We'll soon be able to introduce a solution that not only meets today's challenges but anticipates tomorrow's needs, especially in the day-to-day happenings with our facilities partners." For more information about TransLogic and its offerings, visit About Swisslog Healthcare Swisslog Healthcare provides pharmacy workflow automations through robotic solutions and operational technology that enable hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patients' needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways. For more information, visit About TransLogic™ TransLogic™, a Swisslog Healthcare Company, builds on its 100 years of operational technology expertise to reliably automate the delivery of critical items and leverage innovations which transcend industry standards in transport automation. TransLogic™ products are manufactured in the USA, resulting in nominal supply chain issues, fewer shipping delays, and quality controls which meet North America's standards. Learn more about TransLogic™ solutions at
Business Wire
an hour ago
- Business Wire
Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case
BOSTON--(BUSINESS WIRE)--A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell's mesothelioma was directly caused by the company's iconic, asbestos-laced baby powder. The jury awarded $42,609,300, making it what lawyers believe to be the largest mesothelioma verdict in Massachusetts history. For years, Johnson & Johnson ignored its own internal warnings and scientific evidence about the presence of asbestos in its talc. The jury has sent a strong message: Corporate misconduct will not be tolerated.' Share During the two-week trial, jurors heard compelling arguments from Dean Omar Branham Shirley attorneys Aaron Chapman and Danny Kraft, who detailed how Johnson & Johnson and its affiliated entities knowingly concealed for decades the health risks associated with their talc products. The attorneys presented internal documents showing the company's awareness of asbestos contamination, its failure to adopt safer alternatives and systematic manipulation of scientific testing methods. The jury agreed that the company not only failed to warn consumers, but also actively misled the public and regulators by suppressing test results and spreading false assurances about product safety. "This verdict is not just about Paul Lovell. It's about every consumer who was told these products were safe,' said Mr. Chapman. 'For years, Johnson & Johnson ignored its own internal warnings and scientific evidence about the presence of asbestos in its talc. The jury has sent a strong message: Corporate misconduct will not be tolerated.' Mr. Lovell, 69, and his wife have been married for 45 years. A father of four, he used Johnson's Baby Powder on himself and his children, trusting it was safe. They have lived in the same home in Melrose, Massachusetts, for decades. 'Paul never worked in a factory, never used joint compound, and never had any occupational exposure to asbestos. Instead, like untold millions of Americans, he was a lifelong user of J&J's Baby Powder,' said Mr. Kraft. 'He trusted the product on himself and on his children.' The jury found the company's actions amounted to negligence and breach of warranty. The Lovell family was also represented by Leslie-Anne Taylor of Thornton Law Firm LLP. The case is Paul Lovell and Kathryn Lovell v. Johnson & Johnson, Civil Action No. 21-2086, filed in Middlesex County Superior Court in Massachusetts. Dean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of irresponsible conduct of others. For more information, please visit
